Myelination and node of Ranvier formation on sensory neurons in a defined in vitro system.
One of the most important developmental modifications of the nervous system is Schwann cell myelination of axons. Schwann cells ensheath axons to create myelin segments to provide protection to the axon as well as increase the conduction of action potentials. In vitro neuronal systems provide a unique modality to study a variety of factors influencing myelination as well as diseases associated with myelin sheath degradation. This work details the development of a patterned in vitro myelinating dorsal root ganglion culture. This defined system utilized a serum-free medium in combination with a patterned substrate, utilizing the cytophobic and cytophilic molecules (poly)ethylene glycol (PEG) and N-1[3 (trimethoxysilyl) propyl] diethylenetriamine (DETA), respectively. Directional outgrowth of the neurites and subsequent myelination was controlled by surface modifications, and conformity to the pattern was measured over the duration of the experiments. The myelinated segments and nodal proteins were visualized and quantified using confocal microscopy. This tissue-engineered system provides a highly controlled, reproducible model for studying Schwann cell interactions with sensory neurons, as well as the myelination process, and its effect on neuronal plasticity and peripheral nerve regeneration. It is also compatible for use in bio-hybrid constructs to reproduce the stretch reflex arc on a chip because the media combination used is the same that we have used previously for motoneurons, muscle, and for neuromuscular junction (NMJ) formation. This work could have application for the study of demyelinating diseases such as diabetes induced peripheral neuropathy and could rapidly translate to a role in the discovery of drugs promoting enhanced peripheral nervous system (PNS) remyelination.
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.|College of Medicine, University Central Florida, Orlando, FL 32826, USA.
John W
JW
Rumsey
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.|College of Medicine, University Central Florida, Orlando, FL 32826, USA.
Christopher
C
McAleer
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.|College of Medicine, University Central Florida, Orlando, FL 32826, USA.
Mainak
M
Das
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.
Abhijeet
A
Bhalkikar
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.
Kerry
K
Wilson
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.
Maria
M
Stancescu
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.
Stephen
S
Lambert
NanoScience Technology Center, University Central Florida, Orlando, FL 32826, USA.
James J
JJ
Hickman
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D009186:Myelin Sheath / Q000378:metabolism* / Q000502:physiology; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009924:Organ Culture Techniques; D038081:Organogenesis / Q000187:drug effects*; D017646:Organosilicon Compounds / Q000494:pharmacology; D011073:Polyamines / Q000494:pharmacology; D011092:Polyethylene Glycols / Q000494:pharmacology; D051381:Rats; D012583:Schwann Cells / Q000187:drug effects / Q000378:metabolism*; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D023822:Tissue Engineering
C575344:N-(3-trimethoxysilylpropyl)diethylenetriamine; D017646:Organosilicon Compounds; D011073:Polyamines; D011092:Polyethylene Glycols